Trial intelligence / Profile preview

Radioprotective effect of melatonin during iodine-131 treatment for hyperthyroidism

IRCT2014090419045N1Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin in hyperthyroidism and Acute Radiation Syndrome (ARS), sponsored by Babol University of Medical Sciences. Started Nov 2014; status: completed.

02

Drugs

melatonin
03

Conditions

hyperthyroidismAcute Radiation Syndrome (ARS)

Beyond the preview

Go deeper on IRCT2014090419045N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014090419045N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call